BBIO- Bridgebio Pharma, Inc.

Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.

BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Homcy Charles J	919.9K	-	-
CEO	Kumar Neil	497.0K	$34.30M	-
CFO	Trimarchi Thomas	336.5K	$26.88M	-
Other	Apuli Maricel	122.7K	$9.80M	-
Dir	Cook Jennifer E.	120.8K	$10.15M	-

Buys and sells only

10 filings · page 16

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 3, 2020	Kumar Neil	CEO And President	Sell	5,930	$30.05	$178,173.37	-0.3%
Jun 3, 2020	Stephenson Brian C	See Remarks	Sell	1,600	$30.04	$48,071.84	-0.5%
Jun 3, 2020	Henderson Michael Thomas57	Chief Business Officer	Sell	784	$30.04	$23,548.54	-0.3%
Jun 1, 2020	Kumar Neil	CEO And President	Sell	80,000	$29.19	$2,335,389.61	-3.3%
Jun 1, 2020	Stephenson Brian C	See Remarks	Sell	7,200	$29.36	$211,400.91	-2.3%
Jun 1, 2020	Henderson Michael Thomas57	Chief Business Officer	Sell	2,585	$29.37	$75,911.65	-1.0%
May 5, 2020	Kumar Neil	CEO And President	Sell	79,600	$31.02	$2,469,481.93	-3.2%
May 5, 2020	Stephenson Brian C	See Remarks	Sell	5,706	$30.49	$173,959.39	-1.8%
May 5, 2020	Henderson Michael Thomas57	See Remarks	Sell	1,460	$30.47	$44,493.35	-0.9%
May 4, 2020	Henderson Michael Thomas57	See Remarks	Sell	3,905	$29.52	$115,266.78	-2.3%